Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

A Case of Advanced Gastric Cancer with Peritoneal Metastasis Treated Successfully with Nivolumab.

Tazawa H, Suzuki T, Komo T, Kubota H, Tahara S, Sada H, Hadano N, Shimizu W, Ishiyama K, Onoe T, Sudo T, Shimizu Y, Tashiro H.

Case Rep Oncol. 2019 Jul 16;12(2):523-528. doi: 10.1159/000501717. eCollection 2019 May-Aug.

2.

Safety and Relative Dose Intensity of Dose-dense Doxorubicin and Cyclophosphamide Followed by Dose-dense Paclitaxel.

Nishimura M, Onoe T, Sakai H, Arase M, Watanabe S, Soyama M, Hashimoto K, Miki M, Tane K, Hirokaga K, Takao S, Matsumoto K.

Anticancer Res. 2019 Aug;39(8):4379-4383. doi: 10.21873/anticanres.13607.

PMID:
31366533
3.

Postoperative Portal Hypertension Enhances Alloimmune Responses after Living-Donor Liver Transplantation in Patients and in a Mouse Model.

Hashimoto S, Onoe T, Banshodani M, Taguchi K, Tanaka Y, Ohdan H.

J Immunol. 2019 Sep 1;203(5):1392-1403. doi: 10.4049/jimmunol.1701147. Epub 2019 Jul 22.

PMID:
31331971
4.

PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy.

Matsumoto K, Nishimura M, Onoe T, Sakai H, Urakawa Y, Onda T, Yaegashi N.

Jpn J Clin Oncol. 2019 Jun 26. pii: hyz090. doi: 10.1093/jjco/hyz090. [Epub ahead of print]

PMID:
31242303
5.

Laproscopic treatment for small bowel bleeding after detection by double-balloon endoscopy: A case report.

Akabane S, Suzuki T, Hinoi T, Shimizu Y, Sudo T, Onoe T, Ishiyama K, Shimizu W, Tazawa H, Hadano N, Misumi T, Kojima M, Kubota H, Zaitsu J, Taniyama D, Kuraoka K, Tashiro H.

Int J Surg Case Rep. 2019;59:63-65. doi: 10.1016/j.ijscr.2019.05.003. Epub 2019 May 10.

6.

[Two Cases of Colorectal Liver Metastasis with Localized Biliary Dilatation].

Kubota H, Sudo T, Shimizu Y, Kojima M, Akabane S, Misumi T, Hadano N, Tazawa H, Shimizu W, Suzuki T, Ishiyama K, Onoe T, Hinoi T, Tashiro H.

Gan To Kagaku Ryoho. 2019 Mar;46(3):537-539. Japanese.

PMID:
30914606
7.

Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.

Okano S, Enokida T, Onoe T, Ota Y, Motegi A, Zenda S, Akimoto T, Tahara M.

Int J Clin Oncol. 2019 Jul;24(7):789-797. doi: 10.1007/s10147-019-01418-w. Epub 2019 Feb 22.

PMID:
30796560
8.

A rare case of transient left ventricular apical ballooning syndrome following living donor liver transplantation: A case report and literature review.

Tanaka A, Onoe T, Ishiyama K, Ide K, Tashiro H, Ohdan H.

Int J Surg Case Rep. 2019;55:218-222. doi: 10.1016/j.ijscr.2019.02.002. Epub 2019 Feb 10.

9.

[Surgical Resection of Hepatic Portal Lymph Node Metastasis after Repeated Treatment for Hepatocellular Carcinoma Recurrence].

Ishiyama K, Onoe T, Kubota H, Kojima M, Hadano N, Tazawa H, Shimizu W, Suzuki T, Sudo T, Shimizu Y, Hinoi T, Kuraoka K, Kouno H, Kohno H, Tashiro H.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2003-2005. Japanese.

PMID:
30692425
10.

[A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis Treated with Conversion Surgery after S-1 plus Oxaliplatin Chemotherapy].

Misumi T, Suzuki T, Tazawa H, Kojima M, Kubota H, Akabane S, Hadano N, Shimizu W, Ishiyama K, Onoe T, Sudo T, Shimizu Y, Hinoi T, Tashiro H.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2150-2152. Japanese.

PMID:
30692314
11.

Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Hamauchi S, Yokota T, Mizumachi T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H, Homma A.

Int J Clin Oncol. 2019 May;24(5):468-475. doi: 10.1007/s10147-018-01392-9. Epub 2019 Jan 17.

PMID:
30656463
12.

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.

Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K.

J Clin Oncol. 2019 Mar 1;37(7):570-579. doi: 10.1200/JCO.18.00771. Epub 2019 Jan 17.

PMID:
30653423
13.

Isolation of tumor endothelial cells from murine cancer.

Taguchi K, Onoe T, Yoshida T, Yamashita Y, Taniyama K, Ohdan H.

J Immunol Methods. 2019 Jan;464:105-113. doi: 10.1016/j.jim.2018.11.005. Epub 2018 Nov 3.

PMID:
30395818
14.

LatY136F knock-in mouse model for human IgG4-related disease.

Yamada K, Zuka M, Ito K, Mizuguchi K, Kakuchi Y, Onoe T, Suzuki Y, Yamagishi M, Izui S, Malissen M, Malissen B, Kawano M.

PLoS One. 2018 Jun 14;13(6):e0198417. doi: 10.1371/journal.pone.0198417. eCollection 2018.

15.

A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.

Yokota T, Hamauchi S, Yoshida Y, Yurikusa T, Suzuki M, Yamashita A, Ogawa H, Onoe T, Mori K, Onitsuka T.

Support Care Cancer. 2018 Sep;26(9):3241-3248. doi: 10.1007/s00520-018-4175-4. Epub 2018 Apr 7.

PMID:
29627862
16.

Aneurysm of the inferior vena cava with thrombosis.

Inoue M, Sudo T, Yamaguchi M, Seo S, Miyamoto T, Misumi T, Shimizu W, Irei T, Suzuki T, Onoe T, Shimizu Y, Hinoi T, Tashiro H.

Clin Case Rep. 2018 Jan 13;6(2):402-406. doi: 10.1002/ccr3.1321. eCollection 2018 Feb.

17.
18.

Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).

Tahara M, Kiyota N, Yokota T, Hasegawa Y, Muro K, Takahashi S, Onoe T, Homma A, Taguchi J, Suzuki M, Minato K, Yane K, Ueda S, Hara H, Saijo K, Yamanaka T.

Ann Oncol. 2018 Apr 1;29(4):1004-1009. doi: 10.1093/annonc/mdy040.

PMID:
29408977
19.

[A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer].

Miyamoto T, Inoue M, Tanemura M, Yamaguchi M, Irei T, Tamaru K, Seo S, Misumi T, Shimizu W, Suzuki T, Onoe T, Sudo T, Shimizu Y, Hinoi T, Tashiro H.

Gan To Kagaku Ryoho. 2018 Jan;45(1):88-90. Japanese.

PMID:
29362317
20.

Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors.

Nishikawa T, Matsumoto K, Tamura K, Yoshida H, Imai Y, Miyasaka A, Onoe T, Yamaguchi S, Shimizu C, Yonemori K, Shimoi T, Yunokawa M, Xiong H, Nuthalapati S, Hashiba H, Kiriyama T, Leahy T, Komarnitsky P, Fujiwara K.

Cancer Sci. 2017 Sep;108(9):1834-1842. doi: 10.1111/cas.13307. Epub 2017 Aug 5.

21.

Effect of Fc-γ Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation.

Sakai H, Tanaka Y, Tazawa H, Shimizu S, Verma S, Ohira M, Tahara H, Ide K, Ishiyama K, Kobayashi T, Onoe T, Ohdan H.

Transplant Direct. 2017 May 24;3(6):e164. doi: 10.1097/TXD.0000000000000683. eCollection 2017 Jun.

22.

Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3.

Kawahira M, Yokota T, Hamauchi S, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H.

Jpn J Clin Oncol. 2017 Aug 1;47(8):705-712. doi: 10.1093/jjco/hyx057.

PMID:
28431119
23.

Proton beam therapy for bone sarcomas of the skull base and spine: A retrospective nationwide multicenter study in Japan.

Demizu Y, Mizumoto M, Onoe T, Nakamura N, Kikuchi Y, Shibata T, Okimoto T, Sakurai H, Akimoto T, Ono K, Daimon T, Murayama S.

Cancer Sci. 2017 May;108(5):972-977. doi: 10.1111/cas.13192. Epub 2017 Apr 24.

24.

[A Case of Ovarian Cancer with Lymph Node Metastasis in the Lesser Curvature of the Stomach Resected Using Laparoscopic Surgery].

Tanaka K, Jeongho M, Hatanaka N, Inoue M, Miyamoto T, Yamaguchi M, Seo S, Misumi T, Shimizu W, Irei T, Suzuki T, Onoe T, Sudo T, Shimizu Y, Hinoi T, Tashiro H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2380-2382. Japanese.

PMID:
28133328
25.

[A Case of Angiomyolipoma Occurring in the Mesentery of the Transverse Colon and Treated Using Laparoscopic Excision].

Inoue M, Tanemura M, Hatanaka N, Miyamoto T, Seo S, Yamaguchi M, Misumi T, Shimizu W, Irei T, Onoe T, Suzuki T, Sudo T, Shimizu Y, Hinoi T, Tashiro H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2271-2273. Japanese.

PMID:
28133292
26.

[A Case of Myxofibrosarcoma of the Retroperitoneum].

Inoue M, Yamaguchi M, Kohada Y, Jeongho M, Hatanaka N, Seo S, Misumi T, Shimizu W, Irei T, Suzuki T, Onoe T, Sudo T, Shimizu Y, Hinoi T, Tashiro H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2109-2111. Review. Japanese.

PMID:
28133238
27.

Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.

Kawai S, Yokota T, Onozawa Y, Hamauchi S, Fukutomi A, Ogawa H, Onoe T, Onitsuka T, Yurikusa T, Todaka A, Tsushima T, Yoshida Y, Kito Y, Mori K, Yasui H.

BMC Cancer. 2017 Jan 17;17(1):59. doi: 10.1186/s12885-017-3052-8.

28.

Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study.

Sumita K, Harada H, Asakura H, Ogawa H, Onoe T, Murayama S, Nakamura S, Tanigawa N, Takahashi T, Nishimura T.

Radiat Oncol. 2016 Aug 2;11:104. doi: 10.1186/s13014-016-0673-z.

29.

Prognostic Factors and Multidisciplinary Postoperative Chemoradiotherapy for Clinical T4a Tongue Cancer.

Yokota T, Iida Y, Ogawa H, Kamijo T, Onozawa Y, Todaka A, Hamauchi S, Onoe T, Nakagawa M, Yurikusa T, Tanuma A, Yamashita A, Nishimura T, Yasui H, Onitsuka T.

Oncology. 2016;91(2):78-84. doi: 10.1159/000446439. Epub 2016 Jun 7.

PMID:
27270420
30.

A simple technique to minimize needle displacement in gynecologic interstitial brachytherapy: Use of fully stretched elastic tapes.

Nose T, Onoe T, Otani Y, Oguchi M, Yamashita T.

Brachytherapy. 2016 May-Jun;15(3):347-352. doi: 10.1016/j.brachy.2016.02.009. Epub 2016 Mar 28.

PMID:
27032994
31.

Subclinical generation of acyclovir-resistant herpes simplex virus with mutation of homopolymeric guanosine strings during acyclovir therapy.

Daikoku T, Tannai H, Honda M, Onoe T, Matsuo K, Onoye Y, Nishizawa M, Kawana T, Okuda T, Hasegawa T, Shiraki K.

J Dermatol Sci. 2016 Jun;82(3):160-5. doi: 10.1016/j.jdermsci.2016.02.006. Epub 2016 Feb 15.

PMID:
26917345
32.

Hints to the diagnosis of uromodulin kidney disease.

Onoe T, Yamada K, Mizushima I, Ito K, Kawakami T, Daimon S, Muramoto H, Konoshita T, Yamagishi M, Kawano M.

Clin Kidney J. 2016 Feb;9(1):69-75. doi: 10.1093/ckj/sfv110. Epub 2015 Dec 17.

33.

Prophylactic managements of hepatitis B viral infection in liver transplantation.

Onoe T, Tahara H, Tanaka Y, Ohdan H.

World J Gastroenterol. 2016 Jan 7;22(1):165-75. doi: 10.3748/wjg.v22.i1.165. Review.

34.

Reirradiation of spinal metastases with intensity-modulated radiation therapy: an analysis of 23 patients.

Kawashiro S, Harada H, Katagiri H, Asakura H, Ogawa H, Onoe T, Sumita K, Murayama S, Murata H, Nemoto K, Takahashi M, Nishimura T.

J Radiat Res. 2016 Mar;57(2):150-6. doi: 10.1093/jrr/rrv083. Epub 2015 Dec 10.

35.

Fc-Gamma Receptor Polymorphisms Predispose Patients to Infectious Complications After Liver Transplantation.

Shimizu S, Tanaka Y, Tazawa H, Verma S, Onoe T, Ishiyama K, Ohira M, Ide K, Ohdan H.

Am J Transplant. 2016 Feb;16(2):625-33. doi: 10.1111/ajt.13492. Epub 2015 Oct 30.

36.

Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Hamauchi S, Yokota T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H.

Jpn J Clin Oncol. 2015 Dec;45(12):1116-21. doi: 10.1093/jjco/hyv142. Epub 2015 Sep 29.

PMID:
26423341
37.

A Genetic Variant in the Distal Enhancer Region of the Human Renin Gene Affects Renin Expression.

Makino Y, Konoshita T, Omori A, Maegawa N, Nakaya T, Ichikawa M, Yamamoto K, Wakahara S, Ishizuka T, Onoe T, Nakamura H; Genomic Disease Outcome Consortium (G-DOC) Study Investigators.

PLoS One. 2015 Sep 14;10(9):e0137469. doi: 10.1371/journal.pone.0137469. eCollection 2015.

38.

Preoperative Proton Beam Therapy for Thymoma: A Case Report.

Kojima H, Isaka M, Nagata M, Onoe T, Murayama S, Ohde Y.

Ann Thorac Cardiovasc Surg. 2016 Jun 20;22(3):186-8. doi: 10.5761/atcs.cr.15-00205. Epub 2015 Sep 8.

39.
40.

Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.

Yokota T, Onoe T, Ogawa H, Hamauchi S, Iida Y, Kamijo T, Suda T, Yurikusa T, Nishimura T, Yasui H, Onitsuka T.

Jpn J Clin Oncol. 2015 Feb;45(2):183-8. doi: 10.1093/jjco/hyu196. Epub 2014 Nov 23.

PMID:
25420692
41.

Altered trafficking and stability of polycystins underlie polycystic kidney disease.

Cai Y, Fedeles SV, Dong K, Anyatonwu G, Onoe T, Mitobe M, Gao JD, Okuhara D, Tian X, Gallagher AR, Tang Z, Xie X, Lalioti MD, Lee AH, Ehrlich BE, Somlo S.

J Clin Invest. 2014 Dec;124(12):5129-44. doi: 10.1172/JCI67273. Epub 2014 Nov 3.

42.

Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases.

Irei T, Onoe T, Das LK, Tanimine N, Ishiyama K, Ide K, Kobayashi T, Tashiro H, Ohdan H.

Hepatol Res. 2015 Sep;45(9):1041-1046. doi: 10.1111/hepr.12445. Epub 2014 Nov 21.

PMID:
25355534
43.

Small bowel obstruction due to an unconjugated ursodeoxycholic acid enterolith following living donor liver transplantation: Report of a case.

Mukai S, Onoe T, Tashiro H, Ohdan H.

Hepatol Res. 2015 Jul;45(7):818-22. doi: 10.1111/hepr.12401. Epub 2014 Sep 2.

PMID:
25091893
44.

4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.

Takase N, Matsumoto K, Onoe T, Kitao A, Tanioka M, Kikukawa Y, Yamaguchi S, Fujiwara K, Negoro S.

Int J Clin Oncol. 2015 Jun;20(3):566-73. doi: 10.1007/s10147-014-0731-1. Epub 2014 Jul 18.

PMID:
25030546
45.

Multiple hepatic vein reconstruction using an all-in-one sleeve patch graft technique in living donor liver transplantation: a case report.

Shimizu S, Onoe T, Ishiyama K, Ide K, Ohira M, Tahara H, Saeki Y, Kobayashi T, Kuroda S, Tashiro H, Ohdan H.

Transplant Proc. 2014 Apr;46(3):982-5. doi: 10.1016/j.transproceed.2013.11.105.

PMID:
24767397
46.

Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation.

Abe T, Onoe T, Tahara H, Tashiro H, Ishiyama K, Ide K, Ohira M, Ohdan H.

Transplant Proc. 2014 Apr;46(3):865-9. doi: 10.1016/j.transproceed.2013.12.027.

PMID:
24767367
47.

Xenograft tolerance and immune function of human T cells developing in pig thymus xenografts.

Kalscheuer H, Onoe T, Dahmani A, Li HW, Hölzl M, Yamada K, Sykes M.

J Immunol. 2014 Apr 1;192(7):3442-50. doi: 10.4049/jimmunol.1302886. Epub 2014 Mar 3.

48.

Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection.

Yanai H, Matsuda A, An J, Koshiba R, Nishio J, Negishi H, Ikushima H, Onoe T, Ohdan H, Yoshida N, Taniguchi T.

Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20699-704. doi: 10.1073/pnas.1320808110. Epub 2013 Dec 3.

49.

Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for medulloblastoma in childhood.

Hirano E, Fuji H, Onoe T, Kumar V, Shirato H, Kawabuchi K.

J Radiat Res. 2014 Mar 1;55(2):320-7. doi: 10.1093/jrr/rrt112. Epub 2013 Nov 1.

50.

Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas.

Fuji H, Schneider U, Ishida Y, Konno M, Yamashita H, Kase Y, Murayama S, Onoe T, Ogawa H, Harada H, Asakura H, Nishimura T.

Radiat Oncol. 2013 Nov 1;8:255. doi: 10.1186/1748-717X-8-255.

Supplemental Content

Support Center